FDC
Quarterly Results Analysis [Mar2026]
FDC Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 Audited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹585 Cr | ₹465 Cr | ₹473 Cr | ₹648 Cr | ₹492 Cr | ₹464 Cr | ₹514 Cr | ₹638 Cr |
| Expenses | ₹478 Cr | ₹412 Cr | ₹439 Cr | ₹508 Cr | ₹438 Cr | ₹417 Cr | ₹444 Cr | ₹492 Cr |
| Operating Income | ₹106 Cr | ₹52 Cr | ₹34 Cr | ₹140 Cr | ₹54 Cr | ₹47 Cr | ₹70 Cr | ₹147 Cr |
| Other Income | ₹50 Cr | ₹21 Cr | ₹21 Cr | ₹36 Cr | ₹16 Cr | ₹19 Cr | ₹35 Cr | ₹28 Cr |
| Interest | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹14 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹14 Cr | ₹11 Cr |
| Profit Before Tax | ₹140 Cr | ₹36 Cr | ₹38 Cr | ₹160 Cr | ₹53 Cr | ₹51 Cr | ₹90 Cr | ₹163 Cr |
| Profit After Tax | ₹103 Cr | ₹28 Cr | ₹28 Cr | ₹121 Cr | ₹39 Cr | ₹37 Cr | ₹72 Cr | ₹119 Cr |
| EPS | ₹6.35 | ₹1.74 | ₹1.74 | ₹7.45 | ₹2.38 | ₹2.28 | ₹4.42 | ₹7.31 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | -4% | 2.3% | -8.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -3.6% | 6% |
| DIVIS LABORATORIES | 1.1% | -1.2% | -0.3% |
| TORRENT PHARMACEUTICALS | 1.6% | 1.4% | 36.7% |
| CIPLA | 0.7% | 2.6% | -4.6% |
| DR REDDYS LABORATORIES | -0.9% | -2.5% | 1.2% |
| MANKIND PHARMA | 0.7% | -1.1% | -4.8% |
| LUPIN | 0.4% | -7.1% | 14.8% |
| ZYDUS LIFESCIENCES | -0.2% | 16% | 16.7% |
FDC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 25.84 % |
| Y-o-Y | 18.89 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹585 Cr | 25.84 | |
| Dec2025 | ₹465 Cr | -1.76 | |
| Sep2025 | ₹473 Cr | -27.05 | |
| Jun2025 | ₹648 Cr | 31.82 | |
| Mar2025 | ₹492 Cr | 5.98 | |
| Dec2024 | ₹464 Cr | -9.68 | |
| Sep2024 | ₹514 Cr | -19.49 | |
| Jun2024 | ₹638 Cr | - | |
FDC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 103.45 % |
| Y-o-Y | 97.03 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹106 Cr | 103.45 | |
| Dec2025 | ₹52 Cr | 54.59 | |
| Sep2025 | ₹34 Cr | -75.90 | |
| Jun2025 | ₹140 Cr | 159.98 | |
| Mar2025 | ₹54 Cr | 15.71 | |
| Dec2024 | ₹47 Cr | -33.51 | |
| Sep2024 | ₹70 Cr | -52.15 | |
| Jun2024 | ₹147 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 61.69 % |
| Y-o-Y | 65.82 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 18.19% | 61.69 | |
| Dec2025 | 11.25% | 57.34 | |
| Sep2025 | 7.15% | -66.96 | |
| Jun2025 | 21.64% | 97.27 | |
| Mar2025 | 10.97% | 9.15 | |
| Dec2024 | 10.05% | -26.37 | |
| Sep2024 | 13.65% | -40.57 | |
| Jun2024 | 22.97% | - | |
FDC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 265.33 % |
| Y-o-Y | 167.38 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹103 Cr | 265.33 | |
| Dec2025 | ₹28 Cr | -0.25 | |
| Sep2025 | ₹28 Cr | -76.62 | |
| Jun2025 | ₹121 Cr | 213.81 | |
| Mar2025 | ₹39 Cr | 4.40 | |
| Dec2024 | ₹37 Cr | -48.58 | |
| Sep2024 | ₹72 Cr | -39.48 | |
| Jun2024 | ₹119 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 190.31 % |
| Y-o-Y | 124.94 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 17.68 % | 190.31 | |
| Dec2025 | 6.09 % | 1.50 | |
| Sep2025 | 6 % | -67.95 | |
| Jun2025 | 18.72 % | 138.17 | |
| Mar2025 | 7.86 % | -1.50 | |
| Dec2024 | 7.98 % | -43.08 | |
| Sep2024 | 14.02 % | -24.83 | |
| Jun2024 | 18.65 % | - | |
FDC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 264.94 % |
| Y-o-Y | 166.81 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.35 | 264.94 | |
| Dec2025 | ₹1.74 | 0.00 | |
| Sep2025 | ₹1.74 | -76.64 | |
| Jun2025 | ₹7.45 | 213.03 | |
| Mar2025 | ₹2.38 | 4.39 | |
| Dec2024 | ₹2.28 | -48.42 | |
| Sep2024 | ₹4.42 | -39.53 | |
| Jun2024 | ₹7.31 | - | |
You may also like the below Video Courses